Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: A comparison of conjugation chemistries and compounds

Bioconjugate Chemistry

Volumn 10, Issue 6, 1999, Pages 973-981

  Stanford Lee, L ^a   Conover, Charles ^a   Shi, Celine ^a   Whitlow, Marc ^a,b   Filpula, David ^a  

^a Enzon Incorporated   (United States)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID; CONJUGATION; MACROGOL;

ANTIBODIES; ANTIGENS; BINDING ENERGY; BIOMOLECULES; BODY FLUIDS; CARBOXYLIC ACIDS; CHAINS; POLYETHYLENES;

ANTIGEN BINDING; BIOCONJUGATES; CARBOXYLIC ACID GROUPS; CONJUGATION CHEMISTRY; HALF LIVES; MULTIMERIC; PEGYLATION; PRIMARY AMINES; SINGLE-CHAIN FV; THERAPEUTIC AGENTS;

POLYETHYLENE GLYCOLS;

EID: 0345504113     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc990076o     Document Type: Article

References (46)

1. Hudson, P. J. (1998) Recombinant antibody fragments. Curr. Opin. Biotechnol. 9, 395-402.
2. Dall'Acqua, W., and Carter, P. (1998) Antibody engineering. Curr. Opin. Struct. Biol. 8, 443-450.
3. De Haard, H., Henderikx, P., and Hoogenboom, H. R. (1998) Creating and engineering human antibodies for immunotherapy. Adv. Drug Deliv. Rev. 31, 5-31.
4. Filpula, D., and McGuire, J. (1999) Single-chain Fv designs for protein, cell, and gene therapeutics. Exp. Opin. Ther. Patents 9, 231-245.
5. Kreitman, R. J., and Pastan, I. (1998) Immunotoxins for targeted cancer therapy. Adv. Drug Deliv. Rev. 31, 53-88.
6. Pelegrin, M., Marin, M., Noel, D., and Piechaczyk, M. (1998) Genetically engineered antibodies in gene transfer and gene therapy. Hum. Gene Ther. 9, 2165-2175.
7. Begent, R. H. J., Verhaar, M. J., Chester, K. A., Casey, J. L., Green, A. J., Napier, M. P., Hope-Stone, L. D., Cushen, N., Keep, P. A., Johnson, C. J., Hawkins, R. E., Hilson, A. J. W., and Robson, L. (1996) Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat. Med. 2, 979-984.
8. Fitch, J. C. K., Elefteriades, J. A., Rinder, H. M., Matis, L. A., Evans, M. J., Rollins, S. A., Alford, B. L., and Hines, R. L. (1996) Safety, pharmacokinetics, and immunogenicity of intravenous administration of H5G1.1-SCFV in humans. Blood 88, 654a.
9. Holliger, P., Wing, M., Pound, J. D., Bohlen, H., and Winter, G. (1997) Retargeting serum immunoglobulin with bispecific diabodies. Nat. Biotechnol. 15, 632-636.
10. Whitlow, M., Filpula, D., Rollence, M. L., Feng, S.-L., and Wood, J. F. (1994) Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv. Protein Eng. 7, 1017-1026.
11. Adams, G. P., Schier, R., McCall, A. M., Crawford, R. S., Wolf, E. J., Weiner, L. M., and Marks, J. D. (1998) Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu. Br. J. Cancer 77, 1405-1412.
12. Wang, D., Berven, E., Li, Q., Uckun, F., and Kersey, J. H. (1997) Optimization of conditions for formation and analysis of anti-CD19 FVS191 single-chain Fv homodimer (scFv′)2. Bioconjugate Chem. 8, 64-70.
13. Cao, Y., and Suresh, M. R. (1998) Bispecific antibodies as novel bioconjugates. Bioconjugate Chem. 9, 635-644.
14. Nucci, M. L., Shorr, R., and Abuchowski, A. (1991) The therapeutic value of poly(ethylene glycol)-modified proteins. Adv. Drug Deliv. Rev. 6, 133-151.
15. Francis, G. E., Delgado, C., Fisher, D., Malik, F., and Agrawal, A. K. (1996) Poly(ethylene glycol) modification: Relevance of improved methodology to tumour targeting. J. Drug Targeting 3, 321-340.
16. Zalipsky, S. (1995) Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjugate Chem. 6, 150-165.
17. Clark, R., Olson, K., Fuh, G., Marian, M., Mortensen, D., Teshima, G., Chang, S., Chu, H., Mukku, V., Canova-Davis, E., Somers, T., Cronin, M., Winkler, M., and Wells, J. A. (1996) Long-acting growth hormones produced by conjugation with poly(ethylene glycol). J. Biol. Chem. 271, 21969-21977.
18. Pettit, D. K., Bonnert, T. P., Eisenman, J., Srinivasan, S., Paxton, R., Beers, C., Lynch, D., Miller, B., Yost, J., Grabstein, K. H., and Gombotz, W. R. (1997) Structure-function studies of interleukin 15 using site-specific mutagenesis, poly(ethylene glycol) conjugation, and homology modeling. J. Biol. Chem. 272, 2312-2318.
19. Delgado, C., Pedley, R. B., Herraez, A., Boden, R., Boden, J. A., Keep, P. A., Chester, K. A., Fisher, D., Begent, R. H. J., and Francis, G. E. (1996) Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification. Br J. Cancer 73, 175-182.
20. Benhar, I., Brinkmann, U., Webber, K. O., and Pastan, I. (1994) Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization. Bioconjugate Chem. 5, 321-326.
21. Benhar, I., Wang, Q.-c., FitzGerald, D., and Pastan, I. (1994) Pseudomonas exotoxin A mutants. Replacement of surface-exposed residues in domain III with cysteine residues that can be modified with poly(ethylene glycol) in a site-specific manner. J. Biol. Chem. 269, 13398-13404.
22. Wang, Q.-c., Pai, L. H., Debinski, W., FitzGerald, D. J., and Pastan, I. (1993) Poly(ethylene glycol)-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin. Cancer Res. 53, 4588-4594.
23. Kinstler, O. B., Brems, D. N., Lauren, S. L., Paige, A. G., Hamburger, J. B., and Treuheit, M. J. (1996) Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm. Res. 13, 996-1002.
24. Padlan, E. A. (1994) The structure of antibodies. Molecular Biology Intelligence Unit: Antibody-antigen complexes, pp 17-30, R. G. Landes Company, Austin, TX.
25. Kabat, E. A., Wu, T. T., Perry, H. M., Gottesman, K. S., and Foeller, C. (1991) Sequences of proteins of immunological interest, 5th ed., U.S. Department of Health and Human Services, Bethesda, MD.
26. Wang, M., Lee, L. S., Nepomich, A., Yang, J.-D., Conover, C., Whitlow, M., and Filpula, D. (1998) Single-chain Fv with manifold N-glycans as bifunctional scaffolds for immunomolecules. Protein Eng. 11, 1277-1283.
27. Filpula, D., McGuire, J., and Whitlow, M. (1996) Production of single-chain Fv monomers and multimers. In Antibody Engineering: a Practical Approach (J. McCafferty, H. R. Hoogenboom, and D. J. Chiswell, Eds.) pp 253-268, Oxford University Press, Oxford.
28. Greenwald, R. B., Pendri, A., Martinez, A., Gilbert, C., and Bradley P. (1996) PEG thiazolidine-2-thione, a novel reagent for facile protein modification: Conjugation of bovine hemoglobin. Bioconjugate Chem. 7, 638-641.
29. Martinez, A., Pendri, A., Xia, J., and Greenwald, R. B. (1997) Branched poly(ethylene glycol) linkers. Macromol. Chem. Phys. 198, 2489-2498.
30. Hermanson, G. T. (1996) Modification with synthetic polymers. Bioconjugate Techniques, pp 605-618, Academic Press, San Diego CA.
31. Whitlow, M., Bell, B. A., Feng, S.-L., Filpula, D., Hardman, K. D., Hubert, S. L., Rollence, M. L., Wood, J. F., Schott, M. E., Milenic, D. E., Yokota, T., and Schlom, J. (1993) An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Protein Eng. 6, 989-995.
32. Habeeb, A. F. S. A. (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14, 328-336.
33. Zalipsky, S., and Menon-Rudolph, S. (1997) Hydrazide derivatives of poly(ethylene glycol) and their bioconjugates. In Poly(ethyleneglycol) Chemistry and Biological Applications (J. M. Harris and S. Zalipsky, Eds.) pp 318-341, American Chemical Society, Washington DC.
34. Harlow, E., and Lane, D. (1988) Immunoassays. Antibodies: a Laboratory Manual, pp 553-612, Cold Spring Harbor Laboratory, Plainview, NY.
35. Milenic, D. E., Yokota, T., Filpula, D. R., Finkelman, M. A. J., Dodd, S. W., Wood, J. F., Whitlow, M., Snoy, P., and Schlom, J. (1991) Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. 51, 6363-6371.
36. Friguet, B., Chaffotte, A. F., Djavadi-Ohaniance, and Goldberg, M. E. (1985) Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 77, 305-319.
37. Larson, S. M., El-Shirbiny, A. M., Divgi, C. R., Sgouros, G., Finn, R. D., Tschmelitsch, J., Picon, A., Whitlow, M., Schlom, J., Zhang, J., and Cohen, A. M. (1997) Single chain antigen binding protein (sFv CC49). First human studies in colorectal carcinoma metastatic to liver. Cancer 80, 2458-2468.
38. Wu, D., and Pardridge, W. M. (1999) Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc. Natl. Acad. Sci. U.S.A. 96, 254-259.
39. Maeda, H., Kimura, M., Sasaki, I., Hirose, Y., and Konno, T. (1992) Toxicity of bilirubin and detoxification by PEG-bilirubin oxidase conjugate. In Poly(ethylene glycol) Chemistry. Biotechnical and Biomedical Applications (J. M. Harris, Ed.) pp 153-169, Plenum Press, New York.
40. Maeda, H., and Matsumura, Y. (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier Syst. 6, 193-210.
41. Maeda, H., Seymour, L. W., and Miyamoto, Y. (1992) Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjugate Chem. 3, 351-362.
42. Murakami, Y., Tabata., Y., and Ikada, Y. (1997) Tumor accumulation of poly(ethylene glycol) with different molecular weights after intravenous injection. Drug Deliv. 4, 23-31.
43. Marecos, E., Weissleder, R., and Bogdanov, A., Jr. (1998) Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model. Bioconjugate Chem. 9, 184-191.
44. Siemers, N. O., Kerr, D. E., Yarnold, S., Stebbins, M. R., Vrudhula, V. M., Hellström, I., Hellström, K. E., and Senter, P. D. Construction, expression, and activities of L49-sFv-β-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation. Bioconjugate Chem. 8, 510-519.
45. Kraulis, P. J. (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
46. Merritt, E. A., and Bacon, D. J. (1997) Raster3D: Photo-realistic molecular graphics. Methods Enzymol. 277, 505-524.